/

Denali Therapeutics

Developing medicines for neurodegenerative and lysosomal storage diseases.

BiotechnologyPharmaceuticals denalitherapeutics.com ↗

Company facts

Founded: 2013
Employees: 503
Headquarters: United States
Type: Public
Listed: NASDAQ: DNLI